Menin Inhibitors 101 with Dr. Joshua Zeidner image

Menin Inhibitors 101 with Dr. Joshua Zeidner

Posted on: Jul 09, 2024
Play Episode
Description

What are menin inhibitors? How are they used in AML care? Listen to this pre-recorded podcast episode to hear Dr. Joshua Zeidner, an AML expert and lead researcher in menin inhibitors, answer these questions and more by sharing data from one of his recent studies.

On this episode
Healthtree contact Mary Arnett

Mary Arnett

Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Healthtree contact Dr. Joshua Zeidner

Dr. Joshua Zeidner

Dr. Zeidner specializes in the management of patients with acute leukemia, MDS, and MPNs. His research focuses on developing innovative methods to improve clinical outcomes in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Dr. Zeidner is the Chief of the Leukemia Research Program at the University of North Carolina.

Related Content